Financials
Financial year 2025
LMEDICATION from Fleurus, company number BE0789738465, closed financial year 2025 with a result of € 39,690 after tax. For that financial year LMEDICATION recorded a gross margin of € 57,349 and equity of € 44,934. Compared with financial year 2024, the result moved from € 34,152 to € 39,690. Profitable, and profit is growing. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.
€ 44,934
▼ 40% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 39,690
▲ 16% vs 2024
Profit after tax over the fiscal year.
€ 17,467
▲ 64% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 70,000 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
€ 176,577
▲ 78% vs 2024
€ 11,393 is repaid this year. At this pace the long-term loan is gone in ≈ 15 years.
€ 1,071
▲ 67% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 5,265
▼ 70% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 26,511 | € 25,357 | € 49,662 | € 57,349 | ▲ 15% |
| Profit after taxes | € 21,148 | € 16,944 | € 34,152 | € 39,690 | ▲ 16% |
| Equity | € 24,148 | € 41,093 | € 75,245 | € 44,934 | ▼ 40% |
| Total debts | € 8,730 | € 180,096 | € 171,180 | € 183,560 | ▲ 7% |
| Cash | € 31,314 | € 14,341 | € 10,667 | € 17,467 | ▲ 64% |
| Retained profit | € 21,148 | € 38,093 | € 72,245 | € 41,934 | ▼ 42% |
| Dividend | € 0 | € 0 | € 0 | € 70,000 | |
| Bank debt | € 0 | € 108,948 | € 99,196 | € 176,577 | ▲ 78% |
| Balance sheet total | € 32,878 | € 221,189 | € 246,425 | € 228,494 | ▼ 7% |
Key figures of LMEDICATION, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to LMEDICATION?
What happened at LMEDICATION in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 39,690 (▲ 16% vs 2024). Source: NBB ↗
- New establishment in Fleurus. KBO
- Laure MORIMONT became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 21,148 profit in 2022 to € 39,690 profit in 2025.
Paid € 36,475 in corporate taxes since 2022.
Best year ever: 2025, with € 39,690 profit.
Paid out € 70,000 in dividends to the owners in total.
Management
Behind LMEDICATION is Laure MORIMONT .
Directors
According to the 2025 annual accounts
Laure MORIMONT
Director
since 2022
Establishments
Establishment units
Physical locations of this company
Rue Julien Laurent(SA) 7
6221 Fleurus
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0789.738.465
- VAT number
- BE 0789.738.465
- Registered office
- Rue Julien Laurent(SA) 7, 6221 Fleurus
- Names & denominations
- LMEDICATION
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 18 August 2022
- Peppol
- Active · Active since 26 Nov 2025
- Contact
- [email protected] +32477472138
- Activities · NACE
Detailhandel in farmaceutische producten